COMPARISON OF OUTCOMES BETWEEN PATIENTS WITH MYC REARRANGED DLBCL AND DOUBLE/ TRIPLE HIT HIGH‐GRADE B CELL LYMPHOMA: A PAN‐LONDON RETROSPECTIVE REVIEW. (12th June 2019) - El‐Sharkawi, D.; Sharma, S.; Cook, L.; Hanley, B.; Johnston, R.; Arasaretnam, A.; Lazana, I.; Greaves, P.; Parkinson, A.; Peng, Y.; Kassam, S.; Peacock, V.; et al.